Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cefalexin
- Development stage
- Approved
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cefalexin is a first-generation cephalosporin antibiotic used to treat a variety of bacterial infections, including those of the respiratory tract, skin and soft tissue, bone, ear, urinary tract, and genitourinary system. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Cefalexin is effective against many Gram-positive bacteria and some Gram-negative bacteria. It is available as capsules, tablets, and oral suspensions for administration by mouth[1][2][3][4][5].
- Brand names
- KeflexKeftabBiocefPanixine DisperDoseZartanAcfexCephalexCeporexL-XahlMedoxineOspexinTorlasporinNovo-Lexin
- Other names
- cephalexin (USAN, BAN)cefalexina (INN-Spanish)cefalexinum (INN-Latin)cefalessina (DCIT)
02
Targets
PBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on cefalexin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cefalexin.